404 related articles for article (PubMed ID: 28224485)
21. Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia.
Fukuno K; Tomonari A; Takahashi S; Ooi J; Takasugi K; Tsukada N; Konuma T; Iseki T; Moriwaki H; Tojo A; Asano S
Int J Hematol; 2006 Jul; 84(1):79-82. PubMed ID: 16867908
[TBL] [Abstract][Full Text] [Related]
22. Varicella zoster virus: an under-recognised cause of central nervous system infections?
Parkes-Smith J; Chaudhuri A
Intern Med J; 2022 Jan; 52(1):100-104. PubMed ID: 32896944
[TBL] [Abstract][Full Text] [Related]
23. Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?
Cinque P; Bossolasco S; Vago L; Fornara C; Lipari S; Racca S; Lazzarin A; Linde A
Clin Infect Dis; 1997 Sep; 25(3):634-9. PubMed ID: 9314452
[TBL] [Abstract][Full Text] [Related]
24. Fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an HIV-infected patient: a case report.
Fang M; Weng X; Chen L; Chen Y; Chi Y; Chen W; Hu Z
BMC Infect Dis; 2020 Feb; 20(1):159. PubMed ID: 32075599
[TBL] [Abstract][Full Text] [Related]
25. The pharmacokinetic basis of oral valacyclovir treatment of herpes simplex virus (HSV) or varicella zoster virus (VZV) meningitis, meningoencephalitis or encephalitis in adults.
Cunha BA; Baron J
J Chemother; 2017 Apr; 29(2):122-125. PubMed ID: 26239190
[No Abstract] [Full Text] [Related]
26. Clinical and neuroradiologic characteristics in varicella zoster virus reactivation with central nervous system involvement.
Maher MD; Douglas VP; Douglas KAA; Collens SI; Gilbert AL; Torun N; Klein JP; Sobrin L; Buchbinder BR; Gupta R; Mukerji SS; Chwalisz BK
J Neurol Sci; 2022 Jun; 437():120262. PubMed ID: 35489173
[TBL] [Abstract][Full Text] [Related]
27. Neurological complications of varicella zoster virus reactivation.
Nagel MA; Gilden D
Curr Opin Neurol; 2014 Jun; 27(3):356-60. PubMed ID: 24792344
[TBL] [Abstract][Full Text] [Related]
28. Clinical spectrum and prognosis of neurological complications of reactivated varicella-zoster infection: the role of immunosuppression.
Corral C; Quereda C; Muriel A; Martínez-Ulloa PL; González-Gómez FJ; Corral Í
J Neurovirol; 2020 Oct; 26(5):696-703. PubMed ID: 32696182
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of VZV PCR in cerebrospinal fluid in neurological manifestations of varicella].
Levy M; Hentgen V; Marque-Juillet S; Fiot E; Fagherazzi G; Nathanson S; Foucaud P
Arch Pediatr; 2015 May; 22(5):491-7. PubMed ID: 25819633
[TBL] [Abstract][Full Text] [Related]
30. Varicella-zoster virus infections of the central nervous system – Prognosis, diagnostics and treatment.
Grahn A; Studahl M
J Infect; 2015 Sep; 71(3):281-93. PubMed ID: 26073188
[TBL] [Abstract][Full Text] [Related]
31. An unusual presentation of varicella zoster virus with acute cerebellitis and SIADH without a rash.
Lubomski M; Brown L; Markus R
J Clin Neurosci; 2017 Jul; 41():90-91. PubMed ID: 28460866
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of Epstein-Barr virus in the cerebrospinal fluid of immunocompetent patients.
Lee GH; Kim J; Kim HW; Cho JW
Clin Neurol Neurosurg; 2021 Mar; 202():106507. PubMed ID: 33493883
[TBL] [Abstract][Full Text] [Related]
33. Varicella-Zoster Virus in Cerebrospinal Fluid at Relapses of Multiple Sclerosis is Infective in Vitro.
Hernández-González O; Martínez-Palomo A; Sotelo J; Chávez-Munguía B; Ordoñez G; Talamás-Lara D; Pineda B; de Jesús Flores-Rivera J; Espinosa-Cantellano M
Arch Med Res; 2018 Jul; 49(5):350-355. PubMed ID: 30342846
[TBL] [Abstract][Full Text] [Related]
34. [Detection of active varicella-zoster virus (VZV) infection in patients with neurological complications].
Roubalová K; Suchánková A; Bojar M; Glosová L; Machová H; Soltysová K
Klin Mikrobiol Infekc Lek; 2007 Jun; 13(3):109-14. PubMed ID: 17703403
[TBL] [Abstract][Full Text] [Related]
35. Varicella zoster virus infection in neurological patients in Bulgaria.
Shikova E; Kumanova A; Tournev I; Zhelyazkova S; Vassileva E; Ivanov I; Pishmisheva M
J Neurovirol; 2021 Apr; 27(2):272-278. PubMed ID: 33661458
[TBL] [Abstract][Full Text] [Related]
36. High Viral Diversity and Mixed Infections in Cerebral Spinal Fluid From Cases of Varicella Zoster Virus Encephalitis.
Depledge DP; Cudini J; Kundu S; Atkinson C; Brown JR; Haque T; Houldcroft CJ; Koay ES; McGill F; Milne R; Whitfield T; Tang JW; Underhill G; Bergstrom T; Norberg P; Goldstein R; Solomon T; Breuer J
J Infect Dis; 2018 Oct; 218(10):1592-1601. PubMed ID: 29986093
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
Eckerström M; Nilsson S; Zetterberg H; Blennow K; Grahn A
Sci Rep; 2020 Dec; 10(1):22400. PubMed ID: 33372192
[TBL] [Abstract][Full Text] [Related]
38. Absent anti-N-methyl-D-aspartate receptor NR1a antibodies in herpes simplex virus encephalitis and varicella zoster virus infections.
Berger B; Pytlik M; Hottenrott T; Stich O
Int J Neurosci; 2017 Feb; 127(2):109-117. PubMed ID: 26887329
[TBL] [Abstract][Full Text] [Related]
39. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.
Gregoire SM; van Pesch V; Goffette S; Peeters A; Sindic CJ
J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):938-42. PubMed ID: 16844949
[TBL] [Abstract][Full Text] [Related]
40. Biphasic evolution of varicella-zoster virus meningoencephalitis : Diagnostic challenges.
Reizine F; Pronier C; Lepart C; Grolhier C; Revest M; Thibault V; Tattevin P
Med Mal Infect; 2020 Feb; 50(1):87-89. PubMed ID: 31767157
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
